McKool Smith PC is branching out from its Texas roots to open a New York office and has brought in a veteran intellectual property partner from Orrick Herrington & Sutcliffe LLP to lead the firm's practice in the Big Apple.
Google Inc. has hauled in a new law firm to replace part of the popular search engine’s defense team against Viacom Inc.’s $1 billion copyright infringement suit.
A former Mayer Brown LLP patent litigator has joined Kenyon & Kenyon LLP in its New York City office as a partner who will help run the Life Sciences practice, Kenyon announced Thursday.
Crowell & Moring's health care and antitrust groups will soon benefit from the real-world experience of a former in-house counsel of a major medical device company, now that Karen A. Gibbs has joined the firm as a partner.
In a move that will bolster its pharmaceutical and biotechnology practice group, Hogan & Hartson LLP has snagged a new partner who has worked at Amgen Inc. and the U.S. Food and Drug Administration.
Four new partners have joined Duane Morris LLP's intellectual property group, where they will focus mainly on Abbreviated New Drug Applications and other health care matters.
Troutman Sanders LLP has recruited a team of three intellectual property attorneys with expertise in health care trademarks and protection against online infringement in a continued push to build the firm's Raleigh, N.C., branch.
The Washington, D.C., office of Knobbe Martens Olson & Bear LLP opened its doors this week, stepping up the California intellectual property boutique's snowballing international and appellate practices.
Jones Day has bolstered its international intellectual property capabilities with the addition of Martin Weber to its Munich, Germany, office.
The U.S. Food and Drug Administration has snagged Gerald Masoudi from his former post in the Department of Justice's antitrust division to serve as its associate general counsel.
Larry Kocot, a former senior adviser at the Centers for Medicare and Medicaid Services, has joined the health care group at Sonnenschein Nath & Rosenthal LLP, the firm said Tuesday.
International law firm Cadwalader, Wickersham & Taft LLP has established a new intellectual property group, bringing on an experienced IP partner to lead the practice group and adding two special counsel with expertise in the area.
Samuel B. Abrams, formerly a partner in Jones Day’s intellectual property practice, will now serve in the same position in Dechert LLP’s New York City office, Dechert announced Thursday.
Hogan & Hartson LLP has lured a Food and Drug Administration veteran into private practice, where he will help companies navigate the federal regulatory system.
In response to a spike in the U.S. International Trade Commission's involvement in patent spats, McKool Smith PC, long a mainstay on the eastern Texas district court docket, has opened a Washington, D.C., office and stocked it with two intellectual property litigators it grabbed from Adduci Mastriani & Schaumberg LLP.
After years of leading some of the world's biggest companies through trademark, transactional and litigation matters, GlaxoSmithKline PLC's current Vice President of Global Trademarks Scott Thompson has decided to return to private practice with a new position at Greenberg Traurig LLP.
Dewey Ballantine LLP’s intellectual property litigation group has continued its growth with the addition of yet another partner.
In a major push to boost its patent litigation potential, New York-based law firm Dreier LLP has lured an entire patent group away from Greenberg Traurig LLP, Dreier announced Tuesday. The five patent attorneys have a particular expertise in complex biotechnology and pharmaceutical cases.
Schulte Roth & Zabel LLP has scooped up another member for its employment and employee benefits group with the addition of seasoned employment attorney Scott Landau as special counsel, the firm announced Monday.
In an effort to strengthen its white collar defense expertise in the healthcare arena, Fulbright & Jaworski LLP has turned to the public sector, welcoming former New York Special Assistant Attorney General Glenn Jones to its health law practice.
In 2013, we expect to see significant changes in the areas of waste and contamination, including vapor intrusion, waste management and cleanup, brownfields and issues related to real estate purchases. Out of several relevant cases, it will be interesting to watch Soco West v. U.S. Environmental Protection Agency, which challenges a unilateral Resource Conservation and Recovery Act compliance order, say attorneys with McGuireWoods LLP.
Following demands for tougher oversight of energy drinks, the U.S. Food and Drug Administration responded recently that it had no immediate plans to change any relevant laws. If the FDA follows the Canadian authorities' lead on regulating energy drinks, it likely will not introduce any age-related bans but may only change some labeling laws, say Daragh Hoey of Fulbright & Jaworski LLP and Martha Healey of Norton Rose LLP.
With the recent passage of Colorado and Washington voter initiatives, a new marijuana economy is emerging — one in which adults can walk into retail stores and buy locally grown pot that is licensed, taxed and regulated by the state. As entrepreneurs seek to tap into what could prove a multibillion-dollar market, they need to act quickly to secure their branding strategies with proper trademark protections, say attorneys with Stoel Rives LLP.
In the recent ruling of Astiana v. Hain Celestial Group Inc., the U.S. District Court for the Northern District of California dismissed a putative class action alleging that cosmetics manufacturers' "natural" labels were misleading. The opinion reinvigorates a judicial approach that could even the balance between plaintiffs and defendants in such class action, says William Dance of Tucker Ellis LLP.
Differing opinions on claim construction at the Federal Circuit have left patentees uncertain as to what really is the magic formula for understanding the scope of their own inventions. Unfortunately, the U.S. Supreme Court’s recent denial of certiorari in Retractable Technologies v. Becton Dickenson and Company is allowing one of the most vexing conundrums in patent litigation to persist, say Alexander Long and Limor Rabie of Latham & Watkins LLP.
Several U.S. senators recently introduced the Preserve Access to Affordable Generics Act, which would expand Federal Trade Commission powers and alter the legal test governing drug patent settlements. If enacted, the law would gut patent rights in a sector where innovation is vital to human health and welfare. The statutory presumption of patent validity would effectively disappear, say attorneys with Dechert LLP.
This year is sure to bring a number of significant changes to the food and beverage industry, especially given the 2012 election results and the continued momentum of several hot topics from 2012 that attracted the attention of government officials, agencies and the general public. Food labeling, food safety and taxes on sweetened beverages are a few areas in which we expect to see such changes, say attorneys with McGuireWoods LLP and McGuireWoods Consulting LLC.
In recent years, there has been a growing number of consumer fraud class actions brought against the manufacturers of regulated products. The recent case Taradejna v. General Mills Inc. reminds defense attorneys everywhere that when defending claims involving regulated products, it is well worth considering whether the doctrine of primary jurisdiction should result in the dismissal of the plaintiff’s claim, says Brendan Krasinski of Alston & Bird LLP.
There are no more excuses for failing to adopt a comprehensive compliance program — the Centers for Medicare and Medicaid Services has issued a set of final compliance program guidelines applicable to sponsors, which serves as an important road map to health care providers for the development and refinement of compliance programs, say attorneys with Blank Rome LLP.
In the typical traumatic brain injury case, the plaintiff is treated by a neurologist and a neuropsychologist, who generally administers the tests upon which the diagnosis is based. Evaluating these tests can be an important part of discrediting the plaintiff's expert on cross-examination as brain injury claims increase dramatically, says James Hanratty of Marshall Dennehey Warner Coleman & Goggin PC.